US Stock MarketDetailed Quotes

DARE Dare Bioscience

Watchlist

0.4100
-0.0206-4.78%

Close May 31 16:00 ET

0.4090
-0.0010-0.24%

Post 19:31 ET

41.45MMarket Cap-1242P/E (TTM)

Dare Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

57.73%-6.81M

-114.81%-38.86M

-38.70%-8.18M

-192.72%-7.97M

22.04%-6.59M

-30.58%-16.12M

37.11%-18.09M

40.53%-5.9M

551.37%8.6M

28.35%-8.45M

Net income from continuing operations

16.00%-6.76M

2.54%-30.16M

68.28%-5.06M

-18.22%-8.3M

-2,216.49%-8.76M

4.24%-8.04M

20.02%-30.95M

-67.08%-15.94M

44.58%-7.02M

104.52%414K

Operating gains losses

--600K

----

Depreciation and amortization

13.36%10.78K

58.51%38.36K

-6.04%9.98K

205.21%9.26K

80.77%9.62K

81.90%9.51K

-8.37%24.2K

50.73%10.62K

-52.17%3.03K

-19.57%5.32K

Other non cash items

125.34%202.67K

439.59%78.32K

-1,733.84%-108.29K

832.24%198.42K

-616.55%-101.75K

1,021.71%89.94K

55.52%-23.06K

77.95%-5.91K

-234.14%-27.1K

193.59%19.7K

Change In working capital

82.97%-1.5M

-206.01%-11.34M

-138.31%-3.64M

-103.44%-518.5K

117.17%1.62M

-96.73%-8.8M

22.59%10.7M

1,380.43%9.51M

11.58%15.09M

-212.11%-9.43M

-Change in receivables

37.25%-436.46K

235.15%753.95K

-69.34%180.55K

-105.66%-557.29K

117.55%1.83M

-18.99%-695.55K

18.58%-557.84K

159.54%588.88K

251.73%9.85M

-292.22%-10.41M

-Change in prepaid assets

509.46%1.71M

85.55%-605.26K

383.65%1.06M

73.16%-263.29K

-213.98%-987.17K

90.30%-416.46K

-573.17%-4.19M

455.54%219.51K

-87.21%-981.13K

343.98%866.06K

-Change in payables and accrued expense

88.66%-538.3K

-190.00%-6.91M

-171.69%-3.81M

-706.77%-921.85K

134.16%2.56M

-520.24%-4.75M

641.66%7.68M

519.53%5.31M

633.70%151.93K

83.87%1.09M

-Change in other current assets

43.70%-207.14K

-382.19%-10.3K

1,238.58%845.84K

-849.36%-584.04K

--95.83K

---367.93K

-82.51%3.65K

-104.24%-74.29K

-34.22%77.94K

--0

-Change in other current liabilities

-26.04%-120.8K

----

---95.85K

----

-Change in other working capital

23.25%-1.9M

-158.84%-4.57M

-155.53%-1.93M

-69.83%1.81M

-102.01%-1.97M

-242.28%-2.48M

-13.56%7.76M

665.04%3.47M

-46.28%5.99M

-45.17%-976.18K

Cash from discontinued investing activities

Operating cash flow

57.73%-6.81M

-114.81%-38.86M

-38.70%-8.18M

-192.72%-7.97M

22.04%-6.59M

-30.58%-16.12M

37.11%-18.09M

40.53%-5.9M

551.37%8.6M

28.35%-8.45M

Investing cash flow

Cash flow from continuing investing activities

-7.3K

-898.00%-629.43K

-22,418.76%-607.33K

59.82%-22.1K

-334.24%-63.07K

-2.7K

-278.70%-55K

-816

Net PPE purchase and sale

---7.3K

-898.00%-629.43K

-22,418.76%-607.33K

59.82%-22.1K

--0

-334.24%-63.07K

---2.7K

-278.70%-55K

---816

Cash from discontinued investing activities

Investing cash flow

---7.3K

-898.00%-629.43K

-22,418.76%-607.33K

59.82%-22.1K

--0

-334.24%-63.07K

---2.7K

-278.70%-55K

---816

Financing cash flow

Cash flow from continuing financing activities

-98.92%14.03K

1,064.04%15.64M

530,926,900.00%5.31M

192,365.93%8.58M

-66.23%452.2K

1.3M

-98.23%1.34M

-100.00%-1

-99.99%4.46K

-89.90%1.34M

Net issuance payments of debt

---200.39K

--267.19K

---200.39K

----

--0

----

Net common stock issuance

--215.11K

666.91%9.35M

--785.76K

--8.11M

--452.2K

--0

-98.38%1.22M

--0

----

Proceeds from stock option exercised by employees

--0

942.80%1.3M

200.00%1

--0

--1.3M

-76.61%124.6K

-100.00%-1

-97.82%4.46K

--120.15K

Net other financing activities

---690

--4.72M

----

Cash from discontinued financing activities

Financing cash flow

-98.92%14.03K

1,064.04%15.64M

530,926,900.00%5.31M

192,365.93%8.58M

-66.23%452.2K

--1.3M

-98.23%1.34M

-100.00%-1

-99.99%4.46K

-89.90%1.34M

Net cash flow

Beginning cash position

-68.82%10.81M

-32.91%34.67M

-64.77%14.23M

-57.39%13.66M

-49.57%19.83M

-32.91%34.67M

1,006.64%51.67M

-11.37%40.39M

251.97%32.07M

413.27%39.32M

Current changes in cash

54.07%-6.81M

-41.89%-23.85M

41.06%-3.48M

-93.21%580.35K

13.73%-6.13M

-20.00%-14.82M

-135.71%-16.81M

-196.90%-5.9M

-76.59%8.55M

-586.86%-7.11M

Effect of exchange rate changes

-78.26%-39.23K

95.12%-9.59K

-67.34%58.6K

93.49%-15.03K

77.07%-31.15K

-140.49%-22.01K

-208.78%-196.34K

1,063.84%179.43K

-264.64%-230.75K

-1,430.06%-135.87K

End cash Position

-80.00%3.97M

-68.82%10.81M

-64.77%14.23M

-57.39%13.66M

-49.57%19.83M

-32.91%34.67M

-11.37%40.39M

251.97%32.07M

Free cash flow

57.68%-6.82M

-117.54%-39.49M

-48.94%-8.79M

-193.57%-8M

22.05%-6.59M

-30.53%-16.12M

36.93%-18.15M

40.51%-5.9M

554.40%8.55M

28.34%-8.45M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	57.73%-6.81M	-114.81%-38.86M	-38.70%-8.18M	-192.72%-7.97M	22.04%-6.59M	-30.58%-16.12M	37.11%-18.09M	40.53%-5.9M	551.37%8.6M	28.35%-8.45M
Net income from continuing operations	16.00%-6.76M	2.54%-30.16M	68.28%-5.06M	-18.22%-8.3M	-2,216.49%-8.76M	4.24%-8.04M	20.02%-30.95M	-67.08%-15.94M	44.58%-7.02M	104.52%414K
Operating gains losses	--600K	----	----	----	----	----	----	----	----	----
Depreciation and amortization	13.36%10.78K	58.51%38.36K	-6.04%9.98K	205.21%9.26K	80.77%9.62K	81.90%9.51K	-8.37%24.2K	50.73%10.62K	-52.17%3.03K	-19.57%5.32K
Other non cash items	125.34%202.67K	439.59%78.32K	-1,733.84%-108.29K	832.24%198.42K	-616.55%-101.75K	1,021.71%89.94K	55.52%-23.06K	77.95%-5.91K	-234.14%-27.1K	193.59%19.7K
Change In working capital	82.97%-1.5M	-206.01%-11.34M	-138.31%-3.64M	-103.44%-518.5K	117.17%1.62M	-96.73%-8.8M	22.59%10.7M	1,380.43%9.51M	11.58%15.09M	-212.11%-9.43M
-Change in receivables	37.25%-436.46K	235.15%753.95K	-69.34%180.55K	-105.66%-557.29K	117.55%1.83M	-18.99%-695.55K	18.58%-557.84K	159.54%588.88K	251.73%9.85M	-292.22%-10.41M
-Change in prepaid assets	509.46%1.71M	85.55%-605.26K	383.65%1.06M	73.16%-263.29K	-213.98%-987.17K	90.30%-416.46K	-573.17%-4.19M	455.54%219.51K	-87.21%-981.13K	343.98%866.06K
-Change in payables and accrued expense	88.66%-538.3K	-190.00%-6.91M	-171.69%-3.81M	-706.77%-921.85K	134.16%2.56M	-520.24%-4.75M	641.66%7.68M	519.53%5.31M	633.70%151.93K	83.87%1.09M
-Change in other current assets	43.70%-207.14K	-382.19%-10.3K	1,238.58%845.84K	-849.36%-584.04K	--95.83K	---367.93K	-82.51%3.65K	-104.24%-74.29K	-34.22%77.94K	--0
-Change in other current liabilities	-26.04%-120.8K	----	----	----	----	---95.85K	----	----	----	----
-Change in other working capital	23.25%-1.9M	-158.84%-4.57M	-155.53%-1.93M	-69.83%1.81M	-102.01%-1.97M	-242.28%-2.48M	-13.56%7.76M	665.04%3.47M	-46.28%5.99M	-45.17%-976.18K
Cash from discontinued investing activities
Operating cash flow	57.73%-6.81M	-114.81%-38.86M	-38.70%-8.18M	-192.72%-7.97M	22.04%-6.59M	-30.58%-16.12M	37.11%-18.09M	40.53%-5.9M	551.37%8.6M	28.35%-8.45M
Investing cash flow
Cash flow from continuing investing activities	-7.3K	-898.00%-629.43K	-22,418.76%-607.33K	59.82%-22.1K	0	0	-334.24%-63.07K	-2.7K	-278.70%-55K	-816
Net PPE purchase and sale	---7.3K	-898.00%-629.43K	-22,418.76%-607.33K	59.82%-22.1K	--0	--0	-334.24%-63.07K	---2.7K	-278.70%-55K	---816
Cash from discontinued investing activities
Investing cash flow	---7.3K	-898.00%-629.43K	-22,418.76%-607.33K	59.82%-22.1K	--0	--0	-334.24%-63.07K	---2.7K	-278.70%-55K	---816
Financing cash flow
Cash flow from continuing financing activities	-98.92%14.03K	1,064.04%15.64M	530,926,900.00%5.31M	192,365.93%8.58M	-66.23%452.2K	1.3M	-98.23%1.34M	-100.00%-1	-99.99%4.46K	-89.90%1.34M
Net issuance payments of debt	---200.39K	--267.19K	---200.39K	----	----	--0	--0	--0	----	----
Net common stock issuance	--215.11K	666.91%9.35M	--785.76K	--8.11M	--452.2K	--0	-98.38%1.22M	--0	--0	----
Proceeds from stock option exercised by employees	--0	942.80%1.3M	200.00%1	--0	--0	--1.3M	-76.61%124.6K	-100.00%-1	-97.82%4.46K	--120.15K
Net other financing activities	---690	--4.72M	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-98.92%14.03K	1,064.04%15.64M	530,926,900.00%5.31M	192,365.93%8.58M	-66.23%452.2K	--1.3M	-98.23%1.34M	-100.00%-1	-99.99%4.46K	-89.90%1.34M
Net cash flow
Beginning cash position	-68.82%10.81M	-32.91%34.67M	-64.77%14.23M	-57.39%13.66M	-49.57%19.83M	-32.91%34.67M	1,006.64%51.67M	-11.37%40.39M	251.97%32.07M	413.27%39.32M
Current changes in cash	54.07%-6.81M	-41.89%-23.85M	41.06%-3.48M	-93.21%580.35K	13.73%-6.13M	-20.00%-14.82M	-135.71%-16.81M	-196.90%-5.9M	-76.59%8.55M	-586.86%-7.11M
Effect of exchange rate changes	-78.26%-39.23K	95.12%-9.59K	-67.34%58.6K	93.49%-15.03K	77.07%-31.15K	-140.49%-22.01K	-208.78%-196.34K	1,063.84%179.43K	-264.64%-230.75K	-1,430.06%-135.87K
End cash Position	-80.00%3.97M	-68.82%10.81M	-68.82%10.81M	-64.77%14.23M	-57.39%13.66M	-49.57%19.83M	-32.91%34.67M	-32.91%34.67M	-11.37%40.39M	251.97%32.07M
Free cash flow	57.68%-6.82M	-117.54%-39.49M	-48.94%-8.79M	-193.57%-8M	22.05%-6.59M	-30.53%-16.12M	36.93%-18.15M	40.51%-5.9M	554.40%8.55M	28.34%-8.45M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall